Skip to content
10-Q

Quarterly Report

INTERPACE BIOSCIENCES, INC. IDXG

0001493152-25-021928

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 4.43M sh
Cash And Equivalents Q3 2025 · Nov 7, 2025 $2.1M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.42M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $1.46M
Cash And Equivalents restated Q3 2025 · Sep 30, 2024 $1.4M
Shares Diluted Q3 2025 · Sep 30, 2025 27.7M sh
Shares Diluted Q3 2025 · Sep 30, 2025 27.69M sh
Shares Diluted Q3 2025 · Sep 30, 2024 4.42M sh
Shares Diluted Q3 2025 · Sep 30, 2024 4.4M sh
Capex Q3 2025 · Sep 30, 2025 $318K
Capex Q3 2025 · Sep 30, 2024 $747K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $3.69M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $3.46M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$298K
Stockholders Equity Q3 2025 · Jun 30, 2025 −$1.21M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$582K
Stockholders Equity Q3 2025 · Dec 31, 2024 −$2.22M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 −$50.54M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 −$52.28M
Stockholders Equity restated Q3 2025 · Mar 31, 2024 −$54.77M
Stockholders Equity restated Q3 2025 · Dec 31, 2023 −$55.54M
Current Liabilities Q3 2025 · Sep 30, 2025 $5.95M
Current Liabilities Q3 2025 · Dec 31, 2024 $10.62M
Current Liabilities restated Q3 2025 · Sep 30, 2024 $5.9M
Total Liabilities Q3 2025 · Sep 30, 2025 $12.33M
Total Liabilities Q3 2025 · Dec 31, 2024 $17.01M
Current Assets Q3 2025 · Sep 30, 2025 $9.13M
Current Assets Q3 2025 · Dec 31, 2024 $11.77M
Current Assets restated Q3 2025 · Sep 30, 2024 $9.1M
Total Assets Q3 2025 · Sep 30, 2025 $12.04M
Total Assets Q3 2025 · Dec 31, 2024 $14.79M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.03
Eps Diluted Q3 2025 · Sep 30, 2025 $0.07
Eps Diluted restated Q3 2025 · Sep 30, 2024 $0.38
Eps Diluted restated Q3 2025 · Sep 30, 2024 $1.09
Eps Basic Q3 2025 · Sep 30, 2025 $0.21
Eps Basic Q3 2025 · Sep 30, 2025 $0.43
Eps Basic restated Q3 2025 · Sep 30, 2024 $0.38
Eps Basic restated Q3 2025 · Sep 30, 2024 $1.10
Sga Expense Q3 2025 · Sep 30, 2025 $2.06M
Sga Expense Q3 2025 · Sep 30, 2025 $7.27M
Sga Expense Q3 2025 · Sep 30, 2024 $2.54M
Sga Expense Q3 2025 · Sep 30, 2024 $6.92M
Rd Expense Q3 2025 · Sep 30, 2025 $150K
Rd Expense Q3 2025 · Sep 30, 2025 $500K
Rd Expense Q3 2025 · Sep 30, 2024 $199K
Rd Expense Q3 2025 · Sep 30, 2024 $483K
Net Income Q3 2025 · Sep 30, 2025 $911K
Net Income Q3 2025 · Sep 30, 2025 $1.92M
Net Income Q3 2025 · Jun 30, 2025 −$640K
Net Income Q3 2025 · Mar 31, 2025 $1.65M
Net Income restated Q3 2025 · Sep 30, 2024 $1.68M
Net Income restated Q3 2025 · Sep 30, 2024 $4.82M
Net Income restated Q3 2025 · Jun 30, 2024 $2.44M
Net Income restated Q3 2025 · Mar 31, 2024 $708K
Operating Income Q3 2025 · Sep 30, 2025 $1.15M
Operating Income Q3 2025 · Sep 30, 2025 $2.51M
Operating Income restated Q3 2025 · Sep 30, 2024 $2.3M
Operating Income restated Q3 2025 · Sep 30, 2024 $6.05M
Gross Profit Q3 2025 · Sep 30, 2025 $5.44M
Gross Profit Q3 2025 · Sep 30, 2025 $18.09M
Gross Profit restated Q3 2025 · Sep 30, 2024 $7.9M
Gross Profit restated Q3 2025 · Sep 30, 2024 $22.02M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $3.32M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $11.42M
Cost Of Revenue restated Q3 2025 · Sep 30, 2024 $4.39M
Cost Of Revenue restated Q3 2025 · Sep 30, 2024 $12.5M
Revenue Q3 2025 · Sep 30, 2025 $8.76M
Revenue Q3 2025 · Sep 30, 2025 $29.5M
Revenue Q3 2025 · Sep 30, 2024 $12.3M
Revenue restated Q3 2025 · Sep 30, 2024 $34.52M